Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Cost of Revenue (2016 - 2026)

Nuwellis' (NUWE) quarterly Cost of Revenue came in at $471000.0 in Q2 2026, down 38.59% on a YoY basis from $767000.0 in Q2 2025, and down 34.49% quarter-over-quarter from $719000.0 in Q1 2026.

Analysis

Nuwellis (NUWE) Cost of Revenue (2016 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Cost of Revenue for 11 consecutive years, with $471000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cost of Revenue fell 38.59% year-over-year to $471000.0; the trailing twelve-month figure through Jun 2026 stood at $2.7 million (down 16.76% YoY), and the FY2025 full-year result was $3.1 million, up 2.68% from the prior year.
  • Cost of Revenue declined to $471000.0 in Q2 2026 per NUWE's latest filing, from $719000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.2 million in Q4 2023 and bottomed at $471000.0 in Q2 2026.
  • Historically, Cost of Revenue has averaged $837166.7 across 5 years, with a median of $789000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2026: Cost of Revenue soared 34.76% in 2022, then plunged 38.59% in 2026.
  • Over 5 years, Cost of Revenue stood at $1.0 million in 2022, then grew by 15.38% to $1.2 million in 2023, then declined by 16.85% to $967000.0 in 2024, then decreased by 20.37% to $770000.0 in 2025, then slumped by 38.83% to $471000.0 in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $471000.0, $719000.0, and $770000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 5.33 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 931.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 3.42 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 2.09 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 1.59 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 392.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 18.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 478.40 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 808.60 Mn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn 471,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 471,000.00
Mar 31, 2026 719,000.00
Dec 31, 2025 770,000.00
Sep 30, 2025 772,000.00
Jun 30, 2025 767,000.00
Mar 31, 2025 837,000.00
Dec 31, 2024 967,000.00
Sep 30, 2024 711,000.00
Jun 30, 2024 720,000.00
Mar 31, 2024 666,000.00
Dec 31, 2023 1.16 Mn
Sep 30, 2023 1.03 Mn
Jun 30, 2023 928,000.00
Mar 31, 2023 759,000.00
Dec 31, 2022 1.01 Mn
Sep 30, 2022 806,000.00
Jun 30, 2022 1.15 Mn
Mar 31, 2022 824,000.00
Dec 31, 2021 748,000.00
Sep 30, 2021 733,000.00